![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 28, 2008 8:03:34 PM
http://www.stjohnhealthsystem.com/news.asp?id=321&pid=109&task=display&pcatid=
Patients Have New Hope
CyberKnife, a revolutionary advancement in non-invasive cancer treatment, is bringing new hope to patients at St. John Medical Center. St. John recently acquired the highly specialized $3.5 million robotic radiosurgery system which targets and treats tumors once considered inoperable or untreatable, including malignant and benign tumors of the brain, spine, lungs, pancreas, prostate and liver.
CyberKnife utilizes a computer-controlled robotic arm to aim highly concentrated beams of radiation to destroy cancerous and certain non-cancerous cells with pinpoint accuracy within the body. The precise, pencil-thin beams of radiation kill tumor cells while minimizing injury to surrounding healthy tissue. In addition to serving as a cancer treatment option, the CyberKnife also gives patients options for non-surgical treatment of spine and brain issues, as well as diseases of the chest and abdomen.
"With CyberKnife's precision, we can treat tumors previously considered inoperable, including tumors of the brain and spine. St. John is proud to bring this revolutionary technology to Green Country and to offer new hope to many cancer patients, said Frederick Willison, M.D., St. John radiation oncologist.
The revolutionary CyberKnife technology provides a number of benefits over more conventional therapies such as traditional radiotherapy, chemotherapy and surgery. CyberKnife offers many unique benefits for cancer patients and those with other conditions, including benign tumors, vascular malformations and trigeminal neuralgia (cranial nerve pain).
CyberKnife's benefits include:
Non-surgical: Often, there are no incisions. CyberKnife uses the skeletal structure of the body as a reference to track and treat tumors frequently eliminating the use of needles to place the markers used with traditional radiosurgery systems.
Outpatient: Hospitalization is unnecessary.
Painless: CyberKnife is a non-surgical procedure. Because robotic radiosurgery is non-invasive, treatments can be delivered without discomfort and without the risks associated with open surgery.
Convenient: Fewer treatments are required as compared with traditional radiosurgery. Patients require only one to five treatment sessions. Treatments last approximately 60-90 minutes.
No recovery time: Following treatment, a patient can resume normal activity including work.
Frameless: Metal head frames attached with screws are not required with CyberKnife treatment as compared with traditional radiosurgery of the brain.
Accurate: CyberKnife continuously tracks the tumor and adjusts treatment beams due to patient movement. It delivers radiation with sub-millimeter accuracy, minimizing damage to surrounding healthy tissue.
Revolutionary: An option for some inoperable or surgically complex tumors.
St. John Medical Center began offering CyberKnife treatment services October 15 and is the only hospital in the city to offer this cutting-edge technology.
CyberKnife was developed by a team of physicists and engineers at Stanford University and was the first radiosurgery delivery system approved for use by the United States Food and Drug Administration in 2001 for tumors anywhere in the body. CyberKnife is manufactured by Accuray.
Recent ARAY News
- Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration • PR Newswire (US) • 06/12/2024 11:35:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:10:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:10:09 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:01:04 PM
- Accuray to Participate in the Jefferies Global Healthcare Conference 2024 • PR Newswire (US) • 05/22/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:01:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:22:59 PM
- Accuray Reports Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/01/2024 08:06:00 PM
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 • PR Newswire (US) • 04/25/2024 11:35:00 AM
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland • PR Newswire (US) • 04/18/2024 11:35:00 AM
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 • PR Newswire (US) • 04/17/2024 08:05:00 PM
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System • PR Newswire (US) • 03/26/2024 11:35:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:22 PM
- Accuray Incorporated to Speak at 36th Annual Roth Conference • PR Newswire (US) • 03/04/2024 09:30:00 PM
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference • PR Newswire (US) • 02/27/2024 10:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 04:19:22 PM
- Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System • PR Newswire (US) • 02/13/2024 12:35:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 08:01:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:15:46 PM
- Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • PR Newswire (US) • 02/05/2024 10:30:00 PM
- Accuray Reports Fiscal 2024 Second Quarter Financial Results • PR Newswire (US) • 01/31/2024 09:06:00 PM
- Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions • PR Newswire (US) • 01/25/2024 12:35:00 PM
- Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024 • PR Newswire (US) • 01/16/2024 10:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:15:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:15:14 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM